Coriell Extends Its Scope

When New Jersey gave the Coriell Institute for Medical Research $5 million last year, it was the first time any state had funded an umbilical cord blood bank. But no other state has a research institute like Coriell, in Camden, across the Delaware River from Philadelphia. The nonprofit has, for nearly five decades, collected, stored, and cultured cells, providing them to almost every major research center worldwide. Courtesy of Coriell InstituteAn umbilical cord blood cassette used in storing t

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

The new bank will store the umbilical cord blood gathered from the state's newborns. "Having a readily available source of stem cells that can be transplanted into unrelated recipients will be a major advance," said David P. Beck, the institute's president, at the time of the bank's establishment last November.

Cord blood research holds vast potential for therapeutic interventions. One day, it could even be possible to coax stem cells into taking on characteristics of other tissues by selected treatments and culture condition. The new bank will help Coriell with its ongoing research into cord blood, as well as provide a life-saving source of stem cells for bone marrow transplants.

Since its founding in 1953, Coriell has provided millions of cell samples to researchers, serving as the basis for groundbreaking discoveries on Huntington's disease, Alzheimer's disease, hypercholesterolemia, retinitis pigmentosa, and manic-depressive illness, among others, according to Coriell. The institute is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jennifer Fisher Wilson

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours